Last update 21 Nov 2024
Exenokine-21
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Antibody fusion proteins |
Synonyms Recombinant interleukin-21 - human serum albumin nano antibody (Shanghai Junshi) + [2] |
Target |
Mechanism IL-21R agonists(Interleukin 21 Receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Exenokine-21A Phase 1 Study of JS014, a Recombinant Fusion Protein of Interleukin-21 and Humanized Anti-human Serum Albumin VHH Antibody as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Cancer
重组白介素 21-抗人血清白蛋白纳米抗体融合蛋白（JS014）单药及联合特瑞普利单抗在晚期肿瘤患者中的安全性、耐受性、药代动力学和初步疗效的 I 期临床研究
[Translation] Phase I clinical study on the safety, tolerability, pharmacokinetics and preliminary efficacy of recombinant interleukin-21-anti-human serum albumin nanobody fusion protein (JS014) alone and in combination with toripalimab in patients with advanced tumors
100 Clinical Results associated with Exenokine-21
Login to view more data
100 Translational Medicine associated with Exenokine-21
Login to view more data
100 Patents (Medical) associated with Exenokine-21
Login to view more data
100 Deals associated with Exenokine-21
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Phase 2 | CN | 23 Jan 2024 | |
| Lymphoma | Phase 1 | TW | 28 Feb 2022 | |
| Lymphoma | Phase 1 | TW | 28 Feb 2022 | |
| Solid tumor | Phase 1 | TW | 28 Feb 2022 | |
| Solid tumor | Phase 1 | TW | 28 Feb 2022 | |
| Advanced cancer | Phase 1 | CN | 06 Jan 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free